Richard Cappetta has spent the last 25 years as a senior executive in the medical device business focused on interventional technology. Most recently served as President and CEO at MicroVention, Inc, A Terumo Group Company. He also held senior sales and marketing roles at Medtronic Aneurx and Target Therapeutics. Early in his career he worked for SCIMED Life Systems, Trimedyne and CR Bard. He holds a Bachelor of Science degree in Business Administration from Arizona State University.
Professor Berenstein graduated from the Universidad Nacional Autonoma de Mexico and completed his residency in Diagnostic Radiology at Mount Sinai Hospital. He is currently a Clinical Professor of Radiology, Neurosurgery, and Pediatrics at the Icahn School of Medicine at Mount Sinai, where he is the Director of the Hyman-Newman Institute for Neurology and Neurosurgery at the Mount Sinai Health System and Director of Pediatric Endovascular Neurosurgery. Dr. Berenstein developed and pioneered the field of Interventional Radiology. In 2009 he received the most prestigious international award in Endovascular Neurosurgery, the first Serbinenko Golden Sign Award in Neurosurgery, in Moscow. Dr. Berenstein was the first president of the World Federation of Interventional and Therapeutic Neuroradiology.